GeoVax to Host First Quarter 2023 Business Update and Financial Results Conference Call on May 4, 2023
April 25 2023 - 9:00AM
via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a
clinical-stage biotechnology company developing immunotherapies and
vaccines against cancer and infectious diseases, announced today
that it will report first quarter 2023 financial results on
Thursday, May 4, 2023, after the market closes.
Following the release, management will host a live conference
call and webcast to provide a general business update and discuss
financial results. Subsequent to management’s prepared remarks,
there will be a Q&A period for analysts and others.
Thursday, May 4, 2023, 4:30 PM ETDomestic:
800-715-9871International:
646-307-1963Conference ID: 3978501Webcast:
GeoVax
Earnings Webcast
A webcast replay of the call will be available for six months
via the same link as the live webcast approximately two hours after
the end of the call.
About GeoVaxGeoVax Labs, Inc. is a clinical-stage
biotechnology company developing novel therapies and vaccines for
cancers and many of the world’s most threatening infectious
diseases. The company’s lead program in oncology is a novel
oncolytic solid tumor gene-directed therapy, Gedeptin®, presently
in a multicenter Phase 1/2 clinical trial for advanced head and
neck cancers. GeoVax’s lead infectious disease candidate is
GEO-CM04S1, a next-generation COVID-19 vaccine targeting high-risk
immunocompromised patient populations. Currently in two Phase 2
clinical trials, GEO-CM04S1 is being evaluated as a COVID-19
vaccine for immunocompromised patients such as those suffering from
hematologic cancers and other patient populations for whom the
current authorized COVID-19 vaccines are insufficient. In addition,
GEO-CM04S1 is in a Phase 2 clinical trial evaluating the vaccine as
a more robust, durable COVID-19 booster among healthy patients who
previously received the mRNA vaccines. GeoVax has a leadership team
who have driven significant value creation across multiple life
science companies over the past several decades. For more
information, visit our website: www.geovax.com.
Investor Relations Contact:Rich CockrellCG
Capital404-736-3838govx@cg.capital
GeoVax Labs (NASDAQ:GOVXW)
Historical Stock Chart
From Aug 2024 to Sep 2024
GeoVax Labs (NASDAQ:GOVXW)
Historical Stock Chart
From Sep 2023 to Sep 2024